Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (7)
P 1 (1)
P 4 (1)

Trial Status

Active Not Recruiting3
Completed3
Enrolling By Invitation2
Not Yet Recruiting2
Recruiting1
Terminated1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
Showing all 12 trials

Research Network

Activity Timeline